March 4 (Reuters) - Genetic Technologies Ltd (GTG) :
- GENETIC TECHNOLOGIES SIGNS MULTI-YEAR US DISTRIBUTION AGREEMENT FOR COVID RISK TEST
- GENETIC TECHNOLOGIES LTD - CO SIGNS CO-EXCLUSIVE PRODUCTION AND DISTRIBUTION RIGHTS AND LICENSE AGREEMENT WITH INFINITY BIOLOGIX LLC
- GENETIC TECHNOLOGIES LTD - IBX IS REQUIRED TO MAKE MINIMUM PAYMENTS TO CO TOTALING US$2.9 MILLION OVER TERM TO MAINTAIN EXCLUSIVITY
- GENETIC TECHNOLOGIES LTD - UNDERLYING ROYALTY STRUCTURE IS ON A PER UNIT BASIS OF US$10
- GENETIC TECHNOLOGIES LTD - IBX WILL DEFINE AND DECIDE SALES AND END-TO-CONSUMER PRICING STRUCTURE FOR COVID-19 RISK TEST
- GENETIC TECHNOLOGIES LTD - GTG TEAM IS IN FINAL STAGES TO SUBMIT COVID-19 RISK TEST FOR CLEARANCE FROM CLINICAL LABORATORY IMPROVEMENT AMENDMENTS
March 4 (Reuters) - Genetic Technologies Ltd (GTG) : GENETIC...
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
3.9¢ |
Change
0.000(0.00%) |
Mkt cap ! $52.08M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
| GTG (ASX) Chart |
Day chart unavailable